Article Information
History
- April 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Gokul Swaminathan1,#,
- Michael Citron2,
- Jianying Xiao2,
- James E Norton Jr1,
- Abigail L Reens1,!,
- Begüm D. Topçuoğlu1,
- Julia M Maritz1,
- Keun-Joong Lee3,
- Daniel C Freed2,
- Teresa M Weber2,
- Cory H White1,
- Mahika Kadam1,$,
- Erin Spofford4,
- Erin Bryant-Hall4,
- Gino Salituro3,
- Sushma Kommineni1,
- Xue Liang1,
- Olga Danilchanka1,
- Jane A Fontenot5,
- Christopher H Woelk1,
- Dario A Gutierrez1,^,
- Daria J Hazuda1,2 and
- Geoffrey D Hannigan1,#
- 1Exploratory Science Center, Merck & Co., Inc., Cambridge, MA, USA
- 2Infectious Diseases and Vaccine Research, MRL, Merck & Co., Inc., West Point, PA, USA
- 3Pharmacokinetics, Pharmacodynamics & Drug Metabolism, MRL, Merck & Co. Inc, Rahway, NJ, USA
- 4Safety Assessment and Laboratory Animal Research, MRL, Merck & Co. Inc, Boston, MA, USA
- 5New Iberia Research Center, University of Louisiana at Lafayette, LA, USA
- ↵#To whom correspondence should be addressed: Gokul Swaminathan, Email: gokul.swaminathan{at}merck.com, Geoffrey D Hannigan, Email: geoffrey.hannigan{at}merck.com